Abatacept a strong option for rheumatoid arthritis therapy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1663, 2008-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abatacept attains responses in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1463, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Abatacept takes aim at rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Tocilizumab an exciting OPTION in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Modulation of T-Cell Co-Stimulation in Rheumatoid Arthritis: Clinical Experience with Abatacept

By Laganà Bruno   Vinciguerra Marta   D'Amelio Raffaele  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 185-202

Adis International

Access to resources Recommend Favorite

Targeted therapy in rheumatoid arthritis

By Kller Marcus D  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 3, 2008-03 ,pp. : 329-342

Informa Healthcare

Access to resources Recommend Favorite